Laboratorios Farmaceuticos Rovi (ES:ROVI) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Laboratorios Farmacéuticos ROVI, S.A. has received non-binding offers for the purchase of its contract manufacturing business, as part of its strategic evaluation to enhance asset value. The proposals are subject to customary conditions including due diligence and satisfactory contract negotiations. The company will continue to assess the potential transaction’s fit, with any proceeding decision contingent on shareholder approval and regulatory authorization.
For further insights into ES:ROVI stock, check out TipRanks’ Stock Analysis page.